Functional Diversity of Heat-labile Toxins (LT) Produced by Enterotoxigenic Escherichia coli

Heat-labile toxins (LTs) have ADP-ribosylation activity and induce the secretory diarrhea caused by enterotoxigenic Escherichia coli (ETEC) strains in different mammalian hosts. LTs also act as adjuvants following delivery via mucosal, parenteral, or transcutaneous routes. Previously we have shown that LT produced by human-derived ETEC strains encompass a group of 16 polymorphic variants, including the reference toxin (LT1 or hLT) produced by the H10407 strain and one variant that is found mainly among bacterial strains isolated from pigs (LT4 or pLT). Herein, we show that LT4 (with six polymorphic sites in the A (K4R, K213E, and N238D) and B (S4T, A46E, and E102K) subunits) displays differential in vitro toxicity and in vivo adjuvant activities compared with LT1. One in vitro generated LT mutant (LTK4R), in which the lysine at position 4 of the A subunit was replaced by arginine, showed most of the LT4 features with an ∼10-fold reduction of the cytotonic effects, ADP-ribosylation activity, and accumulation of intracellular cAMP in Y1 cells. Molecular dynamic studies of the A subunit showed that the K4R replacement reduces the N-terminal region flexibility and decreases the catalytic site crevice. Noticeably, LT4 showed a stronger Th1-biased adjuvant activity with regard to LT1, particularly concerning activation of cytotoxic CD8+ T lymphocytes when delivered via the intranasal route. Our results further emphasize the relevance of LT polymorphism among human-derived ETEC strains that may impact both the pathogenicity of the bacterial strain and the use of these toxins as potential vaccine adjuvants.

[1]  R. Rappuoli,et al.  Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin , 2009, PloS one.

[2]  Weiping Zhang,et al.  Escherichia coli Constructs Expressing Human or Porcine Enterotoxins Induce Identical Diarrheal Diseases in a Piglet Infection Model , 2008, Applied and Environmental Microbiology.

[3]  M. E. Sbrogio-Almeida,et al.  Cytotoxic T cell adjuvant effects of three Salmonella enterica flagellins , 2008, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[4]  M. E. Sbrogio-Almeida,et al.  Genetic Diversity of Heat-Labile Toxin Expressed by Enterotoxigenic Escherichia coli Strains Isolated from Humans , 2008, Journal of bacteriology.

[5]  R. Moxley,et al.  Significance of Heat-Stable and Heat-Labile Enterotoxins in Porcine Colibacillosis in an Additive Model for Pathogenicity Studies , 2006, Infection and Immunity.

[6]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[7]  T. D. Connell,et al.  Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections , 2005, Journal of dental research.

[8]  J. Mcghee,et al.  Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract , 2005, Infection and Immunity.

[9]  T. D. Connell,et al.  Differential Binding of Escherichia coli Enterotoxins LT-IIa and LT-IIb and of Cholera Toxin Elicits Differences in Apoptosis, Proliferation, and Activation of Lymphoid Cells , 2005, Infection and Immunity.

[10]  K Henrick,et al.  Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. , 2004, Acta crystallographica. Section D, Biological crystallography.

[11]  Lolke de Haan,et al.  Cholera toxin: A paradigm for multi-functional engagement of cellular mechanisms (Review) , 2004, Molecular membrane biology.

[12]  C. Czerkinsky,et al.  Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. , 2003, Vaccine.

[13]  H. Bone,et al.  Mutant Escherichia coli Heat-Labile Toxin B Subunit That Separates Toxoid-Mediated Signaling and Immunomodulatory Action from Trafficking and Delivery Functions , 2003, Infection and Immunity.

[14]  H. Schweizer Vectors to express foreign genes and techniques to monitor gene expression in Pseudomonads. , 2001, Current opinion in biotechnology.

[15]  G. Dougan,et al.  Immunomodulation Using Bacterial Enterotoxins , 2001, Scandinavian journal of immunology.

[16]  T. Sata,et al.  Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain. , 2001, Vaccine.

[17]  E. Ruby,et al.  Vibrio fischeri Genes hvnA andhvnB Encode Secreted NAD+-Glycohydrolases , 2001, Journal of bacteriology.

[18]  R. Rappuoli,et al.  Modulation of Innate and Acquired Immune Responses by Escherichia coli Heat-Labile Toxin: Distinct Pro- and Anti-Inflammatory Effects of the Nontoxic AB Complex and the Enzyme Activity1 , 2000, The Journal of Immunology.

[19]  G. Dougan,et al.  MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants. , 1999, Journal of immunology.

[20]  R. Rappuoli,et al.  Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides. , 1999, Immunology letters.

[21]  W. Hol,et al.  Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat‐labile enterotoxin and its B subunit , 1998, Immunology.

[22]  J. Wilschut,et al.  The role of ADP‐ribosylation and GM1‐binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat‐labile enterotoxin and Vibrio cholerae cholera toxin , 1998, Immunology and cell biology.

[23]  G. Dougan,et al.  Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity , 1998, The Journal of experimental medicine.

[24]  James P. Nataro,et al.  Diarrheagenic Escherichia coli , 1998, Clinical Microbiology Reviews.

[25]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[26]  R. Lechler,et al.  Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. , 1997, Gene.

[27]  J. Kaper,et al.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. , 1996, Microbiological reviews.

[28]  T. Hirst,et al.  Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Hol,et al.  The Arg7Lys mutant of heat-labile enterotoxin exhibits great flexibility of active site loop 47-56 of the A subunit. , 1995, Biochemistry.

[30]  J. Clements,et al.  Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity , 1995, Infection and immunity.

[31]  R. Rappuoli,et al.  A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit , 1994, The Journal of experimental medicine.

[32]  R. Rappuoli,et al.  Common features of the NAD‐binding and catalytic site of ADP‐ribosylating toxins , 1994, Molecular microbiology.

[33]  R. Rappuoli,et al.  Probing the structure‐activity relationship of Escherichia coli LT‐A by site‐directed mutagenesis , 1994, Molecular microbiology.

[34]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[35]  D S Moss,et al.  Main-chain bond lengths and bond angles in protein structures. , 1993, Journal of molecular biology.

[36]  T. Sixma,et al.  Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. , 1993, Journal of molecular biology.

[37]  T. Sixma,et al.  Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli , 1991, Nature.

[38]  M. Petric,et al.  Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin , 1985, Journal of clinical microbiology.

[39]  W. Dallas,et al.  Nucleotide sequence comparison between heat-labile toxin B-subunit cistrons from Escherichia coli of human and porcine origin , 1985, Infection and immunity.

[40]  T. Yamamoto,et al.  Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans. , 1984, The Journal of biological chemistry.

[41]  Y. Takeda,et al.  Molecular heterogeneity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli , 1982, Infection and immunity.

[42]  Y. Takeda,et al.  Immunological nonidentity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli , 1981, Infection and immunity.

[43]  D. A. Yost,et al.  Purification and properties of the soluble NAD glycohydrolase from Bungarus fasciatus venom. , 1981, The Journal of biological chemistry.

[44]  J. Holmgren,et al.  Evaluation of a ganglioside immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin , 1979, Journal of clinical microbiology.

[45]  J. Mekalanos,et al.  Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants , 1978, Infection and immunity.

[46]  R. Collier,et al.  Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa , 1977, Infection and immunity.

[47]  L. Ferreira,et al.  Functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (LT-I) produced by enterotoxigenic Escherichia coli (ETEC). , 2009, FEMS immunology and medical microbiology.

[48]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[49]  D. Ladant,et al.  The comprehensive sourcebook of bacterial protein toxins , 1999 .

[50]  B. Mackler [49] DPNH oxidase of heart muscle , 1967 .